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Adult neurogenesis requires Smad4-mediated bone morphogenic
protein signaling in stem cells
Abstract
In the mammalian brain, neurogenesis continues only in few regions of the forebrain. The molecular
signals governing neurogenesis in these unique neurogenic niches, however, are still ill defined. Here,
we show that bone morphogenic protein (BMP)-mediated signaling is active in adult neural stem cells
and is crucial to initiate the neurogenic lineage in the adult mouse subependymal zone. Conditional
deletion of Smad4 in adult neural stem cells severely impairs neurogenesis, and this is phenocopied by
infusion of Noggin, an extracellular antagonist of BMP. Smad4 deletion in stem, but not progenitor
cells, as well as Noggin infusion lead to an increased number of Olig2-expressing progeny that migrate
to the corpus callosum and differentiate into oligodendrocytes. Transplantation experiments further
verified the cell-autonomous nature of this phenotype. Thus, BMP-mediated signaling via Smad4 is
required to initiate neurogenesis from adult neural stem cells and suppress the alternative fate of
oligodendrogliogenesis.
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In the mammalian brain, neurogenesis continues only in few regions of the forebrain. The molecular signals governing neurogenesis in
these unique neurogenic niches, however, are still ill defined. Here, we show that bone morphogenic protein (BMP)-mediated signaling
is active in adult neural stem cells and is crucial to initiate the neurogenic lineage in the adult mouse subependymal zone. Conditional
deletion of Smad4 in adult neural stem cells severely impairs neurogenesis, and this is phenocopied by infusion of Noggin, an extracel-
lular antagonist of BMP. Smad4 deletion in stem, but not progenitor cells, as well as Noggin infusion lead to an increased number of
Olig2-expressing progeny that migrate to the corpus callosum and differentiate into oligodendrocytes. Transplantation experiments
further verified the cell-autonomous nature of this phenotype. Thus, BMP-mediated signaling via Smad4 is required to initiate neuro-
genesis from adult neural stem cells and suppress the alternative fate of oligodendrogliogenesis.
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Introduction
Progenitors existing in the parenchyma of the adult CNS do not
generate neurons, even after brain injury (Horner et al., 2002;
Buffo et al., 2005) with the exception of cells in the adult stem cell
niches, the subependymal zone (SEZ) and subgranular zone
(SGZ) in the dentate gyrus (Ming and Song, 2005). Astroglia and
radial glia respectively act as stem cells in these niches and gener-
ate transit-amplifying precursors (TAPs) that then give rise to
neuroblasts (Alvarez-Buylla et al., 2001). The adult neural stem
cell niches form a unique neurogenic environment that is suffi-
cient to instruct some progenitors isolated from the adult spinal
cord toward neurogenesis (Shihabuddin et al., 2000). However,
despite the potent function of this niche, we still know little about
the niche signals governing neurogenesis.
Indeed, the adult SEZ retains many developmental character-
istics maintaining the expression of specific extracellular matrix
components and growth factors (Gates et al., 1995; Ninkovic and
Gotz, 2007) including factors that regulate stem cell mainte-
nance, such as PEDF (pigment epithelium-derived factor), Sonic
Hedgehog, and galectin (Ramirez-Castillejo et al., 2006; Sakagu-
chi et al., 2006; Balordi and Fishell, 2007). The platelet-derived
growth factor (PDGF) also affects astrocytes with stem cell prop-
erties that express the PDGF receptor  (PDGFR) (Jackson et
al., 2006) but rather promotes oligodendrogliogenesis than self-
renewal. Thus, in addition to a recently described neurogenic role
of BDNF (Young et al., 2007), still little is known about extrinsic
factors promoting neurogenesis in the SEZ.
On the contrary, more is known about intrinsic fate determi-
nants of adult neurogenesis, such as the transcription factors
Pax6 (Hack et al., 2005; Kohwi et al., 2005) andMash1 (Parras et
al., 2004). Conversely, Olig2 promotes oligodendrogenesis and
rather blocks neurogenesis in the SEZ (Hack et al., 2005). Because
these transcription factors are expressed in neuroblasts and the
transit-amplifying precursors, the obvious question is how ex-
pression of these factors, promoting either the neurogenic or the
oligodendrogliogenic lineage, is regulated. Previous analysis sug-
gested that the bone morphogenic protein (BMP) signaling
would inhibit neurogenesis and secretion of Noggin from the
ependymal cells was crucial to allow neurogenesis in the adult
SEZ (Lim et al., 2000).However, overexpression of BMP receptor
1a in the postnatal SEZ did not affect neurogenesis (Coskun et al.,
2001). Thus, the exact role of this versatile signaling pathway
exerting multiple diverse roles in the developing nervous system
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has yet to be resolved in relation to adult neurogenesis. Indeed, it
has recently been shown that the same signaling molecule, Sonic
Hedgehog, may exert different effect on adult neural stem cells,
TAPs, or neuroblasts, respectively (Balordi and Fishell, 2007).
Here, we examined the activity and function of BMP-
mediated signaling in the adult SEZ and show that this pathway is
active and required in adult SEZ stem cells to allow neurogenesis
and inhibit oligodendrogliogenesis.
Materials andMethods
Animals. In all experiments, 9- to 10-week-old animals were used. The
Smad4 floxed/floxed mouse line (Yang et al., 1998) was received on a
129/FVB and Black Swiss background and crossed to C57BL/6/J. GLAST:
CreERT2 mice, BRE-EGFP mice (R. Monteiro, S. M. Chuva da Sousa
Lopes, C. Mummery, unpublished observations) and Tgfbr2 floxed/
floxed mice (Leveen et al., 2002) were maintained on C57BL/6/J back-
ground. hGFAP-eGFP mouse line (Nolte et al., 2001) was received and
maintained on CD1 background.
Tamoxifen administration. Tamoxifen (Sigma, St. Louis, MO; T-5648)
was dissolved in corn oil (Sigma; C-8267) at 20 mg/ml, and 1 mg was
injected intraperitoneally twice a day for 5 consecutive days (Mori et al.,
2006). Animals were killed either 10 or 21 d after the end of tamoxifen
application.
Neurosphere assay. SEZ of GLAST:CreERT2/Smad4wt/wt or
Smad4wt/fl as controls and GLAST:CreERT2/Smad4fl/fl were dissected
immediately or 21 d after the end of tamoxifen application, dissociated as
previously described (Johansson et al., 1999; Berninger et al., 2007), and
cultured at low density (10 cells/l) to ensure the clonal origin of neuro-
spheres (Morshead et al., 1994). Secondary neurospheres were counted
7 d after passage.
Histological procedures and 5-bromodeoxyuridine labeling. For immu-
nohistochemistry, animals were deeply anesthetized and then transcar-
dially perfused with 4% paraformaldehyde in PBS. Brains were cyropro-
tected, cut, and stained according to standard protocols. Primary
antibodies were directed against the following: phospho-Smad1/5/8
(rabbit; Cell Signaling Technology, Beverly, MA), doublecortin (DCX)
(guinea pig; Chemicon, Temecula, CA), 5-bromodeoxyuridine (BrdU)
(rat; Abcam, Cambridge, MA), glial fibrillary acidic protein (GFAP)
(mouse; DakoCytomation, HighWycombe, UK; or rabbit; Sigma), Dlx2
(rabbit; Chemicon), Olig2 (rabbit; Chemicon), Mash1 (mouse; kind gift
from F. Guillemot, National Institute for Medical Research, Mill Hill,
London, UK), S100 (mouse; Sigma), PDGFR (rabbit; Spring Bio-
sciences), CNPase (mouse; Sigma), CC1 (mouse; Calbiochem, La Jolla,
CA), myelin oligodendrocyte glycoprotein (MOG) (mouse; kind gift
from C. Linington, University of Aberdeen, Aberdeen, UK), TGF re-
ceptor II (rabbit; Santa Cruz Biotechnology, Santa Cruz, CA), and
p-Smad2/3 (rabbit; Cell Signaling Technology). Antibodies were diluted
in 0.1 M PBS (0.5% Triton X-100, 10% normal serum). Appropriate
species/subclass-specific secondary antibodies conjugated to FITC,
TRITC (1:200; Jackson ImmunoResearch, West Grove, PA), or biotin
(1:200; Vector Laboratories, Burlingame, CA), or the tyramide signal
amplification kit (PerkinElmer, Wellesley, MA) were used for additional
detection and stainings were analyzed at a Olympus (Tokyo, Japan)
FV1000 laser-scanning confocal microscope with optical sections of 1
m intervals.
For detection of proliferating cells, theDNAbase analogBrdU (Sigma)
was injected intraperitoneally (100 mg/kg body weight) 1 h before per-
fusion to label fast proliferating cells (short pulse). To label slow dividing
stem cells, BrdU was given in the drinking water (1 mg/ml) for 2 weeks
followed by another 2 weeks with BrdU-free drinking water. Terminal
deoxynucleotidyl transferase-mediated biotinylated UTP nick end label-
ing (TUNEL) staining was done using the cell death kit (Roche, India-
napolis, IN).
In situ hybridization. Mouse cDNAs of BMP ligands (kind gift from
B. L.M.Hogan, DukeUniversityMedical Center, Durham,NC), Noggin
(kind gift from R. M. Harland, University of California, Berkeley, CA),
BMPRII (kind gift fromM. Ruat, Neurobiology Institute Alfred Fessard,
Gif-sur-Yvette, France), Smad4 (kind gift from Y. Chai, University of
Southern California, Los Angeles, CA), and Ids (kind gift from K. Miya-
zono, University of Tokyo, Tokyo, Japan) are used as templates for in situ
hybridization probes. Smad4 probe binds to a region corresponding
exon 6–10 of transcript. Digoxigenin-labeled RNA probes were synthe-
sized by in vitro transcription using the NTP labeling mix from Roche
and T3, T7, or SP6 polymerase from Stratagene (La Jolla, CA). In situ
hybridizations were performed on 20-m-thick cyrostat sections with
hybridization buffer containing 0.5% CHAPS (3-[(3-cholamido-
propyl)dimethylammonio]-1-propanesulfonic acid) according to stan-
dard protocols. Fluorescent in situ hybridization was performed with
HNPP fluorescent detection set (Roche).
Noggin infusion.Noggin (Peprotech, Rocky Hill, NJ) dissolved in arti-
ficial CSF (aCSF) or aCSF only was infused at a rate of 500 ng/d for 7 d
into the lateral ventricle of C57BL/6/J mice at the coordinates0.2 (an-
terioposterior), 1 (mediolateral), 2 (dorsoventral) by osmotic
minipumps (1 l/h ALZET osmotic minipumps 2001; Sigma; Brain In-
fusion Kit II; Sigma). Animals were killed 3 d after Noggin infusion.
Viral vectors and stereotaxic injections.Murine leukemia virus (MLV)-
derived retrovirus pseudotyped with the VSV-G (vesicular stomatitis
virus glycoprotein) expressing either green fluorescent protein (GFP) or
Cre recombinase were prepared as previously described (Hack et al.,
2005). CMV (cytomegalovirus) promoter containing lentiviral vectors
expressing either GFP (LV-GFP) or Cre (LV-Cre) are based on a previ-
ously described vector system (Pfeifer et al., 2001) and were produced as
described previously (Pfeifer et al., 2002). For stereotaxic injections,mice
were anesthetized (ketamine, 100 mg/kg, ketavet; Amersham Bio-
sciences, Erlangen, Germany; and xylazine, 5 mg/kg, Rompun; Bayer,
Leverkusen, Germany) injected with 1l of viral suspension at the coor-
dinates 0.6 (anterioposterior), 1.2 (mediolateral), and 2–1.7 (dorsoven-
tral) relative to bregma (Saghatelyan et al., 2004) for SEZ. For additional
details, see Buffo et al. (2005) and Hack et al. (2005); and for coordinates
for corpus callosum (CC) injections, see Menn et al. (2006).
Transplantation. For transplantation experiments Myristoyl (myr)-
Venus animals were used. In this mouse line, Venus protein is fused with
Myristoyl protein, which is a lipid-modified protein present in plasma
membrane of all cells (Rhee et al., 2006). SEZ of 6-week-old myr-Venus
animals were dissected and prepared for transplantation as described
previously (Seidenfaden et al., 2006; Berninger et al., 2007). A total of
30,000 cells was transplanted into the SEZ at the coordinates described
above. Venus protein was detected with GFP antibody.
Quantitative analysis.Quantifications (absolute cell numbers, marker
coexpression) were performed bymeans of Neurolucida connected to an
Axiophot Zeiss (Oberkochen, Germany) microscope (40 objective).
The analysis was performed on sagittal sections at mediolateral levels
from 0.6 to 1mm relative tomidline (three to seven sections per animal).
The SEZ area analyzedwas 60,000m2 limited to 50–100maway from
the ependymal cell layer, which is corresponding to almost whole SEZ at
those levels. Statistical analysis was performed by unpaired Student’s t
test, and all numbers were expressed as mean SEM.
Results
Activity of BMP-mediated signaling in adult neural stem cells
of the SEZ, but not SGZ
Consistent with previous data (Lim et al., 2000; Peretto et al.,
2002, 2004; Fan et al., 2003), we noted the local enrichment of
several components of the BMP pathway along the lateral wall of
the lateral ventricle (Fig. 1A–G). These include mRNA tran-
scripts of the BMP ligands 2, 4, 6, and 7 (Fig. 1A–D), the feedback
inhibitor Noggin (Fig. 1E), the BMP-specific type II receptor
(BMPRII) (Fig. 1F), the transcription factor Smad4 thatmediates
BMP signaling (Fig. 1G), and Id1 and -3 (Fig. 1H) (data not
shown), which act as downstream targets of the BMP pathway.
This expression pattern prompted us to examine whether BMP-
mediated signaling activity can be detected in the adult SEZ. Be-
cause the receptor Smads 1, 5, and 8 are specifically phosphory-
lated and translocated to the nucleus after heterodimerization
with Smad4 on BMP binding to the receptor dimer (Wrana,
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2000; Shi and Massague, 2003), we moni-
tored BMP activity by immunostaining for
the phosphorylated forms of Smads 1, 5,
and 8 (p-Smad1/5/8). Indeed, many
p-Smad1/5/8-positive (p-Smad1/5/8)
nuclei were detected along the lateral wall
of the lateral ventricle (Fig. 1 I–O), indicat-
ing active BMP signaling in this zone. In
contrast, we hardly observed p-Smad1/5/8
immunoreactivity in the adult SGZ,
whereas pyramidal neurons in the CA re-
gions were positive (supplemental Fig. 1A,
available at www.jneurosci.org as supple-
mental material). Similarly, p-Smad1/5/8
immunostaining was detectable in some
neuronal populations in the forebrain, but
not in parenchymal glia (data not shown)
(for Smad4, see supplemental Fig. 1H,H,
available at www.jneurosci.org as supple-
mental material). Thus, outside the SEZ,
p-Smad1,5,8 immunoreactivity wasmostly
restricted to postmitotic neurons.
In contrast, within the SEZ, the majority
ofp-Smad1/5/8 cells (60%)wereastrocytes
(GFAP) (Fig. 1I,N,P). To determine
whether the p-Smad1/5/8 astrocytes
(GFAP) contain self-renewing stem cells,
we used a label-retaining protocol. Addition
of the DNA-base analog BrdU for 2 weeks to
the drinkingwater followed by 2weeks with-
out BrdU allows labeling slow-dividing cells
that maintain BrdU in contrast to the fast-
proliferating TAPs that dilute the BrdU in
further cell divisions that they undergo dur-
ing the 2 weeks when no BrdU was added to
thedrinkingwater. Inaddition to labeling the
slow-dividing stemcells, this protocol also la-
bels any cells that leave the cell cycle shortly
after incorporating BrdU, such as newly gen-
erated DCX neuroblasts (30% of BrdU-
retaining cells are DCX). Although the
BrdU-retainingpostmitoticneuroblastswere
not p-Smad1/5/8, 43%(n 48 cells) of the
remaining BrdU-retaining cells expressed
p-Smad1/5/8(Fig.1O), suggesting thatahigh
fraction of slow-dividing stem cells is subject
toBMPsignaling.To further ensure the iden-
tity of these cells as stem cells, we stained for
PDGFR as amarker for the stem cell subset among SEZ astrocytes
(Jackson et al., 2006). Indeed, these cells were subject toBMP signal-
ing as observedbyp-Smad1,5,8 immunoreactivity (data not shown)
orbyGFPexpression in aBMPreportermouse line (supplemental
Fig. 1D–D, available at www.jneurosci.org as supplemental
material). In this mouse line, GFP is expressed under the con-
trol of the BMP-specific responsive element (BRE) containing
Smad 1 and 5 binding sites derived from the Id1 promoter
(Monteiro, Chuva da Sousa Lopes, Mummery, unpublished
observations). Consistent with the localization of p-Smad1/
5/8, GFP colocalized with GFAP, but not with DCX in the
adult SEZ of the BRE-GFP mice (supplemental Fig. 1B–B,C,
available at www.jneurosci.org as supplemental material).
Thus, the Smad-mediated BMP-signaling pathway is active in
stem cells of the adult SEZ, but not in neuroblasts.
The remaining (DCX- and GFAP-negative) population is
mostly composed of TAPs that express transcription factors of
the Dlx family (Doetsch et al., 2002). Indeed, all DCX- and
GFAP-negative p-Smad1/5/8 cells were Dlx2-immunoreactive
(Fig. 1L,P). In contrast, p-Smad1/5/8 immunoreactivity did not
colocalize with the transcription factorOlig2 (Fig. 1M) expressed
by a subset of TAPs (Hack et al., 2005; Menn et al., 2006). Thus,
p-Smad1/5/8 cells responding to BMP signaling in the adult
SEZ are composed of 60% of astrocytes and slow-dividing stem
cells and 40% of Dlx2 TAPs (Fig. 1P).
Conditional deletion of Smad4 in the adult SEZ
To understand the role of BMP signaling in the adult SEZ, we
used first a genetic approach by conditionally deleting Smad4, the
common mediator of BMP and TGF signaling. To ensure
Smad4 expression in the cells found to be responsive to BMP, we
Figure1. Expression and functional activity of BMPsignaling components in the adult SEZ.A–H, In situhybridizationofmRNA
transcripts ofBMP ligands (A–D), theextracellular inhibitornoggin (E), BMP receptor II (F ), the central signalingmediator Smad4
(G), and the downstream target Id3 (H ). I–O, Fluorescent micrographs of double immunostainings for the BMP ligand specific
phosphorylated Smads 1/5/8 (p-Smad1/5/8)with different cell type-specific antigens in the adult SEZ as indicated in the panels.
Thearrows in thepanels indicatedouble-labeled cells. Note that p-Smad1/5/8 is containedmostly inGFAP (I,N ) and some fast
proliferating BrdU cells (J ), but not in DCX neuroblasts (K ). p-Smad1/5/8 also colocalizes with the transcription factor Dlx2
(L), but not Olig2 (M ) (note that there are p-Smad1/5/8 cells also in the choroid plexus).O, Fluorescentmicrograph depicting
the colocalization of p-Smad1/5/8 with BrdU in BrdU-retaining cells of the SEZ. The quantitative composition of the p-Smad1/
5/8-immunopositive cell pool is depicted in the pie diagram in P. LV, Lateral ventricle; Str, striatum; ChP, choroid plexus. The
orientationof the sections is indicatedunderD, depictingdorsal; V, depicting ventral; R, depicting rostral; andC, depicting caudal.
Scale bars: (in H ) A–H, 100m; (inM ) I–O, 70m.
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examined Smad4mRNA by fluorescent in situ hybridization. In-
deed, also Smad4 transcripts colocalized with GFAP in the adult
SEZ, but not in other brain regions (supplemental Fig. 1E–H,
available at www.jneurosci.org as supplemental material). This
allowed us to take advantage of the GLAST:CreERT2 mouse line
(Mori et al., 2006) that expresses the inducible form of Cre in the
locus of the astrocyte-specific glutamate transporter (GLAST),
permitting the induction of Cre recombinase activity specifically
in adult astroglial cells and stem cells by tamoxifen administra-
tion. Because Smad4 is not expressed in astrocytes outside the
SEZ, GLAST:CreERT2 mediated excision of exon 8 of Smad4
(Smad4fl/fl) (Yang et al., 2002) is specific to the astrocytes and
stem cells in the SEZ.Moreover, GLAST is not expressed in other
cell types in the SEZ, such as ependymal cells (Mori et al., 2006)
(see also below).
When these mouse lines were crossed and tamoxifen was
given to adult control littermates with either no (GLAST:Cre-
ERT2/Smad4wt/wt) or only a single allele of Smad4 floxed
(GLAST:CreERT2/Smad4wt/fl) strong in situ hybridization sig-
nal for Smad4 was present in the SEZ (Fig. 2A). In contrast,
Smad4 mRNA was virtually undetectable in the SEZ of adult
GLAST:CreERT2/Smad4fl/fl mice (referred to as Smad4/
throughout the text) 10 d after tamoxifen application (Fig. 2B).
Because phosphorylated Smads require Smad4 to localize to the
nucleus (Wrana, 2000), we checked p-Smad1/5/8 localization
10 d after tamoxifen application. Indeed, very few p-Smad1/5/8
nuclei could be detected in the Smad4/ SEZ in contrast to the
many positive nuclei in the controls (Fig. 2C,D). Similarly,
GLAST:CreERT2/Smad4fl/flmice treatedwith corn oil instead of
tamoxifen containedmany p-Smad1/5/8nuclei in the SEZ sim-
ilar to GLAST:CreERT2/Smad4wt/fl mice treated with tamoxifen
(data not shown). The loss of both the Smad4 in situ signal and
the p-Smad1/5/8 immunostaining in tamoxifen-treated GLAST:
CreERT2/Smad4fl/fl mice was specific to SEZ astrocyte-derived
lineages. Smad4 mRNA or p-Smad1/5/8 was still present in neu-
rons of the cerebral cortex and the CA3 region of the hippocam-
pus or the choroid plexus (data not shown). Thus, tamoxifen-
induced recombination in GLAST cells very efficiently deleted
Smad4 and interfered with p-Smad1/5/8 translocation to the nu-
clei in the adult SEZ only.
Smad4 deletion does not affect neural stem cell number and
properties, but reduces neurogenesis
Because Smad4 was deleted in astrocytes, we first examined the
astrocytes labeled by GFAP in the adult SEZ in the Smad4/
compared with control mice (Fig. 3A,B). However, Smad4 dele-
tion had no effect on the number of GFAP cells in the SEZ
neither at 10 d after tamoxifen (Fig. 3E) nor at later stages (21 d)
(data not shown). However, many GFAP cells do not prolifer-
ate and Smad4 may act only in the slow-dividing GFAP cells,
the stem cells. We therefore quantified the number of label-
retaining BrdU (DCX-negative) cells and found it not to be
different between the genotypes (supplemental Fig. 2A–D, avail-
able at www.jneurosci.org as supplemental material). Similarly,
no difference in neurosphere formation (primary and secondary,
supplemental Fig. 2E, available at www.jneurosci.org as supple-
mental material) was observed. Thus, deletion of Smad4 in adult
neural stem cells does not interfere with the stem cell number and
their self-renewal in vitro or in vivo.
Because p-Smads 1/5/8 and Smad4 (data not shown)were also
detected in TAPs, we examined their number by labeling with a
1 h BrdU pulse (TAPs, BrdUDCX cells). Again, no difference
was observed between the genotypes in the number of TAPs (Fig.
3E). However, the DCX staining applied on these sections re-
vealed a consistent decrease in immunoreactivity in the
Smad4/ SEZ compared with controls (Fig. 3C,D). Indeed,
quantification of the number of DCX cells in the SEZ revealed
a reduction to one-half of the control values (Fig. 3E). Notably,
also GLAST:CreERT2/Smad4fl/fl animals that were treated with
corn oil instead of tamoxifen did not show a reduction in neuro-
genesis (three animals). To follow recombined cells after Smad4
deletion, we crossed GLAST:CreERT2/Smad4fl mice with the
Figure 2. Inducible deletion of Smad4 in adult astrocytes and neural stem cells in the adult
SEZ. A, B, In situ hybridization of Smad4mRNA in the adult SEZ 10 d after activation of CreERT2
expressed in the GLAST locus (GLAST:CreERT2) by tamoxifen in mice without (A) or with (B)
exon 8 of Smad4 flanked by loxP sites. Note the loss of Smad4 mRNA in B versus A. C, D,
Fluorescent micrographs of p-Smad1/5/8 immunostaining in GLAST:CreERT2 mice WT for the
Smad4 locus (C) or homozygous for the floxed exon 8 of Smad4 (D) 10 d after induction of
Cre-mediated recombination by tamoxifen. Note the widespread loss of nuclear localization of
p-Smad1/5/8 after deletion of Smad4 (D). The arrows in D indicate some of the remaining
p-Smad1/5/8 cells also demonstrating the same quality of immunostaining. LV, Lateral ven-
tricle; D, dorsal; V, ventral; R, rostral; C, caudal. Scale bars: (in B) A, B, 100m; (in D) C, D, 100
m.
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ROSA26 reporter line (R26R) (Soriano, 1999) in which LacZ
expression is initiated on Cre-mediated recombination and the
progeny of the recombined cells can be traced. The same results,
namely a reduction in the number of DCX, but not TAPs and
GFAP cells, were observed for reporter cells in the SEZ of
GLAST:CreERT2/Smad4fl/fl/ROSA26 mice (supplemental Fig.
3, available at www.jneurosci.org as supplemental material).
Thus, the similar numbers of TAPs and GFAP cells cannot be
explained by a compensatory increase in the number of WT cells
at the expense of mutant cells. Rather, these results suggest that
deletion of Smad4 does not affect stem cell numbers and proper-
ties, but strongly affects neurogenesis.
Deletion of Smad4 alters TAP identity by aberrant expression
of Olig2
To understand how neurogenesis is reduced on Smad4 deletion,
we first examined whether neuroblasts may die. However, the
number of Tunel cells was not different in the Smad4/ or
control SEZ 10 d after tamoxifen application [control, 1.8 0.8;
Smad4/, 1.4 0.4 (per SEZ area, seeMaterials andMethods);
three animals each), suggesting that the reduction in neuroblasts
is not because of cell death. The reduction in DCX cells seems
also not attributable to defects in neuroblast proliferation be-
cause a similar proportion of DCX cells incorporated BrdU
(short pulse) in control and Smad4/ mice [percentage DCX
of control, 10  1%; n (cells)  729; Smad4/, 9  1%; n
(cells)  534; three animals each]. These data therefore suggest
that the decrease in neuroblast number on Smad4 deletion may
be caused at earlier stages in the lineage, consistent with the lo-
calization of p-Smad1/5/8 in cells of earlier lineage stages.
Because the above results also demonstrated normal stem cell
numbers and self-renewal as well as normal numbers of TAPs, we
hypothesized that the molecular identity of TAPs may be altered
in a way to interfere with their progression toward the neuroblast
fate. Indeed, immunostaining for Olig2 revealed a prominent
increase in the number of Olig2 cells in the SEZ of Smad4/
mice to double the number in control mice (Fig. 4B,E,G). Be-
cause the total number of TAPs was not increased (Fig. 3E), the
upregulation ofOlig2 either occurs within the TAPpopulation or
ectopically in astrocytes or neuroblasts. However, virtually no
colocalization of Olig2 and GFAP or DCX was detectable in the
Smad4/ SEZ (data not shown). Instead, Olig2 was frequently
found colocalized with Dlx2 in the Smad4/ SEZ, which was
never observed in the SEZ of control mice (Fig. 4C,F,G). Because
Olig2 overexpressionwas previously shown to interferewith neu-
rogenesis in the adult SEZ (Hack et al., 2005), we examined
whether upregulation of Olig2 in Dlx2 cells may divert these
from their normal neurogenic lineage. Dlx2 cells normally
comprise 	70% DCX neuroblasts and 30% DCX-negative
TAPs (Fig. 4A,H). However, 10 d after Smad4 deletion, the
DCX neuroblast population among Dlx2 cells was reduced,
leading to a reduction in the total number of Dlx2 cells (Fig.
4D,H). However, among Dlx2 cells, the DCX-negative frac-
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bination. E, Histogram depicting the number of GFAP-immunopositive astrocytes and stem
cells [n (cells) 2922 (control), 2531 (Smad4/); 4 animals each], the number of TAPs
(BrdU, DCX) labeled with BrdU 1 h before kill [n (cells) 240 (control), 426 (Smad4/
); 3 animals each] and the number of DCX neuroblasts [n (cells) 11,752 (control), 5400
(Smad4/); 4 animals each] 10 d after tamoxifen application. Note the significant reduction
of neuroblasts, but not TAPs and GFAP cells 10 d after Smad4 deletion. Error bars indicate
SEM. *p
 0.05. LV, Lateral ventricle. Scale bar: (in D) A, B, 75m; C, D, 100m. SEZ area
indicates 60,000m2 (see also Materials and Methods).
Figure 3. Cell fate analysis after deletion of Smad4 in the adult SEZ. A–D, Fluorescent mi-
crographs depicting GFAP immunostaining for astrocytes and stem cells (A, B) and DCX immu-
nostaining for neuroblasts (C, D) in the adult SEZ 10 d after induction of Cre-mediated recom-
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tion increased to 46% (Fig. 4H). Interestingly, the non-
neuroblast fraction was mostly composed of Dlx2/
Olig2double cells (Fig. 4H), consistent with the notion that
the aberrant expression of Olig2 may interfere with the progres-
sion toward the neuroblast stage (Hack et al., 2005).
Deletion of Smad4 results in migration of cells to the corpus
callosum and increased oligodendrogliogenesis
Because Olig2 cells normally migrate from the SEZ to the CC
(Menn et al., 2006) and Olig2 overexpression results in a strong
increase in the number of cells migrating to the CC (Hack et al.,
2005), we hypothesized that the TAPs misspecified after Smad4
deletion may also leave the SEZ and head toward the CC. To test
this possibility, we injected retroviral vectors containingGFP into
the SEZofGLAST:CreERT2/Smad4fl/fl or controlmice 10 d after
the end of tamoxifen application and examined the location of
GFP cells 10 d later (20 d after the end of tamoxifen applica-
tion). In control mice, only 2% of GFP-labeled cells migrated
from the SEZ to the CC (Fig. 5A–C), consistent with previous
observations (Hack et al., 2005; Menn et al., 2006). However, up
to 30% of all cells labeled by injection into the Smad4/ SEZ
were located in the CC 10 d later (Fig. 5A–C) (for control exper-
iments assessing the behavior of cells labeled along the injection
track, see supplemental Fig. 4, available at www.jneurosci.org as
supplemental material). These results thus demonstrate that
manymore cells originating in the SEZmigrate far into theCCon
Smad4 deletion in adult neural stem cells. To assess the fate of the
GFP cells that had migrated from the SEZ into the CC, we
stained for PDGFR to detect immature oligodendrocyte pro-
genitors and CC1 or CNPase for oligodendrocytes at later stages.
Indeed,most of theGFP cells in theCCwere PDGFR (80%)
(Fig. 5D,F) and 	60% were CC1, consistent with their pro-
gression along the oligodendroglial lineage. To assess the addi-
tional maturation of cells that migrated from the SEZ to the CC,
we analyzed the brains at later stages after viral vector injection
(21–30 d) (Fig. 5G–H). Most cells labeled with GFP virus in the
SEZ that had migrated into the CC exhibited additional mature
features of oligodendrocytes in regard to their morphology (Fig.
5G) and the expression of MOG (Fig. 5H–H), a protein con-
tained only inmature oligodendrocytes. Thus, a large proportion
of TAPs upregulate Olig2 after Smad4 deletion and then give rise
to cells migrating to the CC and differentiating into oligodendro-
cytes rather than generating neuroblasts migrating to the OB.
This phenotypemay obviously depend onOlig2 upregulation,
because Olig2 was previously shown to direct SEZ cells toward
the generation of cells migrating toward the CC (Hack et al.,
2005). However, Smad4 deletion may result in deregulation of
many other direct or indirect downstream targets in addition to
Olig2. We therefore asked whether the upregulation of Olig2 is
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the adult SEZ of GLAST:CreERT2micewithout (A–C) or with (D–F ) floxed exon 8 of Smad4 10 d
after tamoxifen application. G, H, Histograms depicting the number of Dlx2 TAPs
(Dlx2DCX) (G) [n (cells) 652 (control), 562 (Smad4/); 3 animals each], the number
of Olig2 cells (G) [n (cells) 255 (control), 513 (Smad4/); 3 animals each], and the
number of Olig2- and Dlx2-double-positive cells (G) [n (cells) 107; 3 animals each] or the
number of all Dlx2 cells (H ) [n (cells) 1430 (control), 834 (Smad4/); 3 animals each]
with the percentage of DCX or Olig2 colocalization in the adult SEZ of GLAST:CreERT2
without (control) or with floxed exon 8 of Smad4 (Smad4/) 10 d after tamoxifen applica-
tion. Note the increase in Olig2 expression in the Dlx2DCX population and corresponding
decrease in the fractionofDlx2DCX. Error bars indicate SEM.**p
0.01. Thedashedwhite
line inA, C,D, and Fdepicts the ventricular surface of the SEZ. LV, Lateral ventricle; Str, striatum;
D, dorsal; V, ventral; R, rostral; C, caudal. Scale bars: (inE)B–E, 100m; (inF )A,C,D,F, 60m.
Figure 4. Alteration of transit-amplifying precursor fate on Smad4 deletion. A–F, Fluores-
cencemicrographs depicting DCX andDlx2 double staining (A,D), Olig2 immunostaining (B, E),
and Dlx2/Olig2 double stainings (C, F ) (double-positive nuclei are indicated by arrowheads) in
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really the key factor for this lineage diver-
sion by attempting a rescue via suppression
of Olig2 function. The fusion of Olig2 to
the strong activator VP16 has previously
been shown to antagonize the endogenous
function of Olig2 that acts as a repressor
(Mizuguchi et al., 2001; Buffo et al., 2005;
Hack et al., 2005). We therefore injected a
previously described virus containing
Olig2VP16, IRES, and GFP (Mizuguchi et
al., 2001; Buffo et al., 2005; Hack et al.,
2005) into the SEZ of Smad4/mice (ta-
moxifen was applied 10 d before virus in-
jection as above). The proportion of
Olig2VP16 transduced cells migrating to
theCCwas significantly reduced compared
with the cells infected with a control virus
in Smad4/ mice (Fig. 5C). Even more
strikingly, the proportion of Olig2VP16-
GFP cellsmigrating via the rostralmigra-
tory stream (RMS) to the olfactory bulb
(OB) was increased to normal wild-type
(WT) levels as observed on GFP virus in-
jection into control mice (Fig. 5C). Thus,
suppression of Olig2 function achieves a
rather complete rescue of the defective
neurogenesis on Smad4 deletion.
WTcells transplanted into the Smad4/
SEZ are not impaired in neurogenesis
Because deletion of Smad4 in all astrocytes
of adult SEZ may change the niche signals
and thereby contribute to the defects in
neurogenesis, we examined the function of
the neurogenic niche by transplanting a
small number of WT cells into 6-week-old
control and Smad4/ mice (Fig. 6A).
Toward this aim, adult SEZ cells were iso-
lated from 6-week-old animals expressing
the green fluorescent protein Venus tar-
geted to the plasma membrane ubiqui-
tously (Rhee et al., 2006). A total of 30,000
cells was transplanted into the SEZ of con-
trol or Smad4/mice 10 d after the end
of tamoxifen application. Notably, at this
time point neurogenesis was decreased and
Olig2 expression was increased in the
Smad4/ mice (Figs. 3, 4). Consistent
with our aim to expose WT cells to a mu-
tant environment, in most cases only a sin-
gle Venus cell was detected in each sec-
tion 7 d after transplantation. When we
examined the identity of the transplanted
Venus cells (Venus protein is detected by
GFP antibody) in the SEZ, RMS, and OB,
most of them were DCX neuroblasts, in
both a control or Smad4/ SEZ environ-
ment (Fig. 6B,C) [percentage of DCX
cells: 80 2%, control (44 cells); 78 5%, Smad4/ (71 cells);
two animals each].
Because even specified neuroblasts change their fate toward a
non-neurogenic lineage on transplantation at positions outside
the SEZ (Seidenfaden et al., 2006), we conclude from our trans-
plantation experiments that the environment in the Smad4/
SEZ niche is still sufficient to support neurogenesis. To further
ensure this, we transplanted cells isolated from 6-week-old
hGFAP-eGFP mice (Nolte et al., 2001). GFP is expressed in as-
trocytes and stem cells in the adult SEZ and only persists for a
Figure 5. Smad4 deletion results in increased migration of SEZ-derived cells toward the corpus callosum and the generation
ofmatureoligodendrocytes.A,B, Fluorescentmicrographsdepicting the locationofGFP cells 10dafterGFP-virus injection into
the SEZ of GLAST:CreERT2 without (A) or with (B) floxed exon 8 of Smad4 10 d after tamoxifen application. The arrowheads
indicateGFP cells located in theCC. Thearrow inBhighlights the small number ofGFP cells remaining in the SEZ after Smad4
deletion.C, Histogramdepicting thepercentageof GFP cells located in the SEZ, RMS,OB, andCC10dafter injection into the SEZ
of GLAST:CreERT2 without [control, n (animals)  3; n (cells)  1404] or with floxed exon 8 of Smad4 [Smad4/, n
(animals) 3; n (cells) 440] 10 d after tamoxifen application. Note the increase of GFP-labeled cells in the CC and the
corresponding decrease of GFP-labeled cells in the OB on Smad4 deletion. The third bar represents Olig2VP16-GFP injection into
SEZ of GLAST:CreERT2 with floxed exon 8 of Smad4 [n (cells) 528; 2 animals]. Note that the interference with Olig2 function
fully rescues the generation of neuroblasts migrating via RMS to the OB in Smad4/ mice. Error bars indicate SEM. D, E,
Fluorescent micrographs of GFP cells in CC expressing immature (PDGFR) (D) and partially mature (CC1 and/or CNPase) (E)
oligodendrocyte markers. F, Histogram depicting the proportion of PDGFR or CC1 and/or CNPase cells among the
GFP cells labeled in the SEZ that then migrated into the CC. Note that virtually all the increased number of cells migrated into
the CC in the Smad4/ differentiated along the oligodendroglial lineage. G, Fluorescent micrograph depicting themorphol-
ogy of GFP cells in CC 21 d after virus injection in the SEZ of Smad4/. H–H, Fluorescent micrographs of GFP cells
expressingMOG, one of themature oligodendrocytemarker, in CC of Smad4/mice 30d after virus injection into the SEZ. The
arrows inH–H indicate processes positive for both GFP andMOG. *p
 0.05; **p
 0.01. LV, Lateral ventricle; Str, striatum; D,
dorsal; V, ventral; R, rostral; C, caudal. Scale bars: (in B) A, B, 100m; (in H) D, G, H–H, 60m; E, 30m.
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short time into their progeny (neuroblasts labeled with BrdU 7 d
before were no longer GFP immunopositive). This implies that
GFP neuroblasts that we detected 1 week after transplantation
have been derived within the host environment from stem cells
(or someprogenitor cells at earlier lineage stages). Aswe observed
indeed 7 d after transplantation a similar rate of neuroblasts dif-
ferentiation in bothWT and Smad4/ SEZ environment (per-
centage DCX of GFP cells: 28 13% inWT, n 157; 32 3%
in Smad4/, n 198), we conclude that the neurogenic niche
in the Smad4/ SEZ is not altered sufficiently enough, if at all,
to impair neurogenesis asWT cells progress normally along their
neuronal fate. Thus, Smad4 acts in a cell-autonomousmanner to
allow neurogenesis by Olig2 suppression.
Smad4 is required at early stages in the stem
cell-derived lineage
Because the above results support a cell-autonomous function of
Smad4, we next asked at which stage in the neural stem cell-
derived lineage Smad4 is required. Toward this end, we deleted
Smad4 at different stages in the lineage. To delete Smad4 in all
fast-proliferating cells of the SEZ (TAPs and neuroblasts) and
spare the stem cells, we targeted Cre by the Moloney-based viral
(MLV) vectors that require the breakdown of the nuclear enve-
lope during cell division to incorporate their genome (Fig. 7).
Figure 6. Differentiation of WT cells transplanted into Smad4/ SEZ. A, Schematic dia-
gramdepicting theexperimental designof theVenus labeled cells into theSEZofGlast:CreERT2/
Smad4fl/fl animals. B–C, Fluorescent micrographs depicting localization and DCX expression
of GFP-labeled cells 7 d after transplantation in the SEZ (B–B) and OB (C–C). Note that
GFP-labeled cells generated DCX neuroblasts and were capable of migrating to the OB after
transplantation into the SEZ of Smad4/. LV, Lateral ventricle. Scale bar: (in C)B, C, 50m;
B–C, 20m.
Figure 7. Deletion of Smad4 in stem cells or transit-amplifying cells results in different
phenotypes. A, Histogram depicting the identity of GFP-positive cells 2 d after injection of
retroviral or lentiviral vectors into the adult SEZ, respectively. Note that retroviral mediated
gene transfer occurs only in fast proliferating cells (transit-amplifying precursors and DCX
neuroblasts), but not in astrocytes and stem cells. The latter are preferentially targeted by
lentiviral vectors. B, Lineage diagram depicting viral-specific targeting. C–F, Fluorescent mi-
crographs of GFP cells infectedwith lentiviral (C,D) or retroviral (E,F ) vectors double-stained
for DCX 7 d after injection. Note that fewer Cre/DCX cells were observed when Cre-
containing lentivirus (D), but not Cre-containing retrovirus was used (F ). Examples of double-
positive cells are indicated by arrows.G, Histogramdepicting the number of DCX neuroblasts
among lentiviral and retroviral infectedGFPor Cre cells in theadult SEZof homozygous floxed
Smad4mice 7 d after injection. Note the strong reduction of neuroblasts generated from lenti-
virus Cre-infected cells, whereas the neuroblast progeny of retrovirus Cre-infected cells was not
affected. (Lentivirus: n (animals) 10; n (cells): GFP 572, Cre 830; retrovirus: n (ani-
mals) 6; n (cells): GFP 372, Cre 559.) Error bars indicate SEM. **p
 0.01. Scale bar: (in
F ) C, D, 50m; E, F, 40m.
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Indeed, on injection of MLV-based retroviral vectors containing
GFP into the SEZ, virtually no GFP cells were GFAP 2 d (Fig.
7A) or 7 d later (Hack et al., 2005), indicating that neural stem
cells were not targeted. In contrast, on injection of lentiviral vec-
tors containing GFP (Pfeifer et al., 2001, 2002), the vast majority
of GFP cells are GFAP 2 d after viral injection (Fig. 7A). We
therefore used these viral vectors to target Cre to distinct stem or
progenitor populations in Smad4fl/fl mice (Fig. 7B). Indeed, 7 d
after injection of lentivirus containing Cre into the SEZ of
Smad4fl/fl mice, a strong reduction in the number of DCX cells
was detected among the Cre-infected cells to less than one-third
of the DCX cells among cells infected by the GFP-containing
control virus (Fig. 7C,D,G). In contrast, however, MLV-
retrovirus-mediated deletion of Smad4 by Cre expression in
TAPs and neuroblasts of Smad4fl/fl mice did not show any effect
on the number of DCX neuroblasts 7 d after injection (Fig.
7E–G). Thus, these data suggest a role for Smad4 at an early stage
in the adult neural stem cell-derived neurogenesis.
Interference with BMP- but not TGF-mediated signaling
increases Olig2 and decreases neurogenesis
The above results have shown a role of Smad4 in suppressing the
oligodendroglial lineage when TAPs are generated. Although this
phenotype is consistent with the identity of BMP-responsive cell
types, the stem cells and TAPs, it may also be caused by TGF-
mediated signaling because Smad4 is a central mediator of both
TGF and BMP signaling (Attisano and Wrana, 2002). Indeed,
we also detected phosphorylated Smad 2 and 3, the receptor-
regulated Smads of TGF signaling in the adult SEZ (supplemen-
tal Fig. 5A,B, available at www.jneurosci.org as supplemental
material). We therefore aimed to discriminate the role of the
BMP or TGF pathway, respectively. To block the BMP selec-
tively, we used minipumps to infuse Noggin, an extracellular
inhibitor binding to BMP ligands, but not to TGF (Zimmerman
et al., 1996; Brunet et al., 1998; Shi and Massague, 2003), for 7 d
into the lateral ventricle of WTmice. When mice were examined
3 d after the end of infusion, p-Smad1/5/8 immunostaining
showed a severe decrease in the SEZ after Noggin, but not after
vehicle (aCSF) infusion (Fig. 8A,D), confirming the successful
delivery of Noggin. The number of DCX cells in the SEZ de-
creased after Noggin infusion to less than one-half the number
observed in animals receiving vehicle infusion (Fig. 8B,E,G). In
additional agreement with the results obtained after Smad4 dele-
tion, Noggin infusion also increased the number of Olig2 cells
to double the number obtained after vehicle infusion (Fig.
8C,F,G). Together, the blockade of BMP signaling phenocopies
the main defects observed after deletion of Smad4, suggesting
that BMP is the main neurogenic signal in this regard.
However, we may have missed some contribution of the
TGF-mediated pathway by comparing the Smad4 genetic dele-
tion and Noggin infusion. Therefore, we directly interfered with
TGF signaling by crossing theGLAST:CreERT2mouse linewith
amouse line carrying floxed alleles for the only type II receptor of
this pathway (Tgfbr2fl/fl) that is therefore required to mediate
TGF signaling (Leveen et al., 2002). Animals were analyzed 3
months after tamoxifen application, because only then Tgfbr2
immunoreactivity had disappeared (supplemental Fig. 6A,D,
available at www.jneurosci.org as supplemental material) (data
not shown). However, even at this late stage, we could not detect
any significant changes in the number of neuroblasts or Olig2
cells (supplemental Fig. 6, available at www.jneurosci.org as sup-
plemental material). Thus, TGF-mediated signaling does not
contribute to the striking decrease in neurogenesis and diversion
of the adult stem cell progeny toward an oligodendroglial fate
observed after Smad4 deletion.
Discussion
Here, we demonstrate that BMP signaling is active in neural stem
cells and TAPs and required for adult neurogenesis in the adult
SEZ. Our results show that both genetic deletion of Smad4 and
infusion of Noggin resulted in an increase in Olig2 oligoden-
drocyte precursors at the expense of neurogenesis. This decrease
in neurogenesis could be fully rescued by suppression of Olig2
function. Smad4-mediated BMP signaling is required in a cell-
autonomousmanner at an early stage in the adult neural stem cell
lineage when stem cells give rise to TAPs. Our results therefore
imply BMP as one of the earliest key signals in the adult neural
stem cell niche allowing the progression toward the neurogenic
lineage by inhibiting the generation of oligodendrocytes.
Smad4-mediated BMP signaling positively regulates
neurogenesis in the adult neural stem cell niche
Here, we propose the BMP-mediated Smad pathway as one of the
key factors promoting neurogenesis in the unique neurogenic
environment of the SEZ, but not the SGZ. Using two indepen-
dent means, nuclear localization of p-Smads 1/5/8 and BRE-
driven reporter activity, we demonstrated the activity of the Smad
pathway-dependent BMP signaling in adult neural stem cells and
TAPs. This activity is present close to the ependymal layer despite
the expression of Noggin in ependymal cells (Lim et al., 2000;
Peretto et al., 2004). Thus, rather than fully blocking the binding
of BMP ligands to their receptors, Noggin secretion may adjust
the level of BMP signaling activity. This adjustment may also
depend on the amount and identity of BMP ligands secreted. For
example, BMP7, one of the ligands expressed in the adult SEZ, is
relatively insensitive to Noggin (Zimmerman et al., 1996). Be-
cause different concentrations of BMP are known to exert differ-
ent effects, a tight balance between BMP ligands and inhibitors of
this pathway is particularly important. For example, higher levels
of BMP promote cell death and inhibit proliferation of embry-
onic cortex precursors (Mehler et al., 2000; Hebert et al., 2002),
whereas lower concentrations promoted neuronal and astroglial
differentiation and inhibited oligodendrogliogenesis (Mabie et
al., 1999; Chojnacki and Weiss, 2004). Thus, the level of BMP
signaling may also be critical in the adult SEZ. Indeed, when Lim
et al. (2000) overexpressed BMP7 in the ependymal cells, they
observed a decrease in proliferation that may be responsible for
the decrease in regeneration of neuroblasts after AraC and BMP7
treatment observed by these authors. Recent data also demon-
strated the antiproliferative role of BMP overexpression on the
proliferation of glioblastoma cells in the adult brain (Piccirillo et
al., 2006). Additionally, particularly high levels of BMP may also
act via Smad-independent pathways (Rajan et al., 2003; Nohe et
al., 2004). These considerations therefore imply that raising the
levels of BMP may not necessarily reveal the endogenous func-
tion of BMP signaling at the physiological levels. Indeed, lower-
ing the levels of BMP signaling by Noggin infusion or Smad4
deletion did not affect proliferation, consistent with only high
levels of BMP acting on proliferation.
Given the importance of a precise level of BMP-signaling ac-
tivity, onemay gain better insights by interfering with the endog-
enous levels of BMP or its signaling mediators. Our results ob-
tained by lowering the levels of BMP activity by Noggin infusion
into the ventricle or deleting the essential signaling mediator
Smad4 revealed the generation of oligodendrocytes at the ex-
pense of neurogenesis. These findings suggest that the endoge-
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nous role of BMP signaling is to allow neurogenesis by suppress-
ing oligodendrogliogenesis. The endogenous levels of Noggin
expressed in the ependymal cells of the adult SEZ may therefore
be crucial to allow the low degree of oligodendrogliogenesis oc-
curring normally (Hack et al., 2005; Menn et al., 2006). Interest-
ingly, oligodendrogliogenesis in the SEZ increases after demyeli-
nation (Nait-Oumesmar et al., 1999, 2007), indicating that
alterations in the stem cell niche may mediate the injury-
triggered signaling. Together, our results imply that the fine-
tuning of progenitors specified toward neurogenesis or oligoden-
drogliogenesis crucially depends on BMP-mediated signaling.
Consistent with our observations in the adult SEZ, BMP sig-
naling inhibits and Noggin application promotes oligodendro-
gliogenesis in the developing nervous system (Hardy and
Friedrich, 1996; Kondo and Raff, 2000; Mekki-Dauriac et al.,
2002; Gomes et al., 2003; Samanta and Kessler, 2004). Interest-
ingly, the inhibition of oligodendrogliogenesis observed during
development occurs sometimes in favor of neurogenesis (Mabie
et al., 1999; Schneider et al., 1999; Muller and Rohrer, 2002;
Chojnacki andWeiss, 2004), and sometimes in favor of astroglial
differentiation (Gross et al., 1996; Gomes et al., 2003). A potential
molecular mechanismmediating these diverse effects may be the
difference in activity of signal transducer and activator of tran-
scription (STAT)-mediated transcription. BMP-mediated effects
on astroglial differentiation are thought to be mediated via the
STAT signaling pathway (Yanagisawa et al., 2001; Rajan et al.,
2003) that is not active in the adult neural stem cell zone (Bauer
and Patterson, 2006). This may explain why BMP does not pro-
mote astrogliogenesis in the adult SEZ. Notably, the STAT-
signaling pathway is activated after injury in the brain paren-
chyma (Okada et al., 2006; Fuller et al., 2007). Therefore, the
coactivation of STAT and Smad-signalingmay explain why BMP
promotes astroglial fate in the injured brain parenchyma (Okada
et al., 2006; Fuller et al., 2007) and why overexpression of Noggin
in the striatal or spinal cord parenchyma (causing injury by in-
jection of the viral vectors) allows transplanted neurosphere cells
to differentiate into neurons (Lim et al., 2000; Setoguchi et al.,
2004). Instead, in the adult SEZ where STAT signaling seems not
to be active, endogenous BMP-mediated signaling via Smad4
promotes neurogenesis and inhibits oligodendrogliogenesis.
Smad4 acts early in the lineage within the adult SEZ
A particularly interesting aspect of our findings is that Smad4-
mediated BMP signaling promotes neurogenesis at very early
stages of the lineage. This is evident from the finding that deletion
of Smad4 in TAPs and neuroblasts by retroviral expression of Cre
had no immediate effect on neurogenesis, whereas deletion of
Smad4 by a lentiviral vector in stem and progenitor cells resulted
in a decrease in neurogenesis. Thus, Smad4-mediated signaling
apparently promotes neurogenesis before the formation of neu-
roblasts at the level of the stemcells, when the identity of theTAPs
is determined. This effect is different from previous effects on
adult neural stem cells that mostly altered their proliferation and
thereby affected neurogenesis (Ramirez-Castillejo et al., 2006;
Sakaguchi et al., 2006). We therefore conclude that Smad4-
Figure 8. Noggin infusion inhibits adult neurogenesis and upregulates Olig2. A–F, Fluores-
centmicrographs depicting p-Smad1/5/8 (A,D), DCX (B, E), and Olig2 (C, F ) cells in the
SEZ 10 d (7 d infusion plus 3 d survival) after aCSF (A–C) or infusion of the extracellular inhibitor
of BMP ligands, Noggin (D–F ) into the lateral ventricle of WT mice. Note the loss of nuclear
p-Smad1/5/8 staining after Noggin infusion in D compared with control in A. Note the severe
4
reduction in neuroblasts inB and E and, conversely, the increase in the number of Olig2 cells
in C and F after Noggin infusion as depicted in the histogram G [for DCX, n (cells) 13,516
(vehicle), 4833 (Noggin), 3 animals each; and for Olig2, n (cells) 168 (vehicle), 332 (Noggin),
3 animals each]. Error bars indicate SEM. *p
 0.05. LV, Lateral ventricle; Str, striatum; D,
dorsal; V, ventral; R, rostral; C, caudal. Scale bar: (in F ) A, C, D, F, 100m; B, E, 120m.
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mediated transcription is required at the transition from stem
cells to TAPs.
Neurogenesis results from inhibition of oligodendrogenesis
in the adult brain
Interestingly, however, interference with Smad4 did not cause a
failure to upregulate the key neurogenic factors, such as Pax6
(Hack et al., 2005) andDlx2 (Doetsch et al., 2002; Petryniak et al.,
2007) but rather lead to the ectopic upregulation of Olig2. Thus,
other signalsmust be crucial for upregulation of these neurogenic
transcription factors, whereas Smad4-mediated transcription is
crucial to suppressOlig2 and thereby restrict the oligodendroglial
lineage. Strikingly, suppression of Olig2 function by the
Olig2VP16 construct was sufficient to rescue the defects in neu-
rogenesis observed after Smad4 deletion, consistent with the
remnant neurogenic potential in these cells in the absence of
Olig2 upregulation. These data henceforth imply the regulation
of the transcription factor Olig2 as a key determinant for the
choice between a neuronal or oligodendroglial lineage in the
adult neural stem cell-derived progeny, reminiscent of its role in
development (Doetsch et al., 2002; Ligon et al., 2006; Petryniak et
al., 2007). Moreover, these data also suggest that TAPs and neu-
roblasts are not yet irreversibly committed to their fate, because
their fate cannot only be altered by overexpression ofOlig2 (Hack
et al., 2005) but also by transplantation of PSA-NCAM neuro-
blasts outside the neurogenic niche (Seidenfaden et al., 2006).
These data therefore underline the importance of a signaling
mechanism maintaining TAPs and neuroblasts within the neu-
rogenic lineage and suppressing Olig2.
Our data imply Smad4-mediated BMP signaling as a key fac-
tor for this role. BMP ligands and BMP-specific p-Smads are
expressed in the SEZ, but not in the RMS. Moreover, BMP-
specific p-Smads are detectable only in stem cells and TAPs, but
not in neuroblasts. Finally, blocking of BMP signaling via Noggin
also leads to the upregulation of Olig2, whereas interference with
the TGF pathway did not, demonstrating the key role of BMP-
mediated signaling in the suppression of Olig2. The observation
that this pathway is present and required at early stages in the
stem cell-derived lineage, is consistent with the need of Olig2
suppression at these early stages in the lineage (Hack et al., 2005).
Our data therefore imply BMP-mediated signaling as one of the
earliest factors in the adult neural stem cell niche to direct the
immediate progeny of stem cells toward a neurogenic fate by
blocking progression toward the oligodendroglial lineage. Nota-
bly, outside the neurogenic niche, virtually all progenitors are
oligodendrocyte progenitors in the adult mammalian brain
(Horner et al., 2002; Dawson et al., 2003) and suppression of
Olig2 function in these cells in the cortical parenchyma also leads
to upregulation of Pax6 and neurogenesis (Buffo et al., 2005).
One may therefore speculate that a key aspect of the adult neu-
rogenic niche is to suppress oligodendrogliogenesis, the apparent
default pathway in the adult mammalian brain.
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